Abcuro, Inc

Siamab Therapeutics Inc is a biopharmaceutical company based in Newton, MA, focused on developing novel cancer therapeutics. The company specializes in leveraging its proprietary technology to create targeted antibody-drug conjugates for the treatment of various types of cancer. With a strong emphasis on research and innovation, Siamab Therapeutics Inc is dedicated to advancing the field of oncology through the development of cutting-edge therapies that have the potential to improve patient outcomes. The company's mission is to address unmet medical needs in cancer treatment and contribute to the advancement of personalized medicine. Generated from their business information

Elevian, Inc. is a biotechnology company based in Newton, MA, dedicated to developing innovative medicines that promote recovery and regeneration. Their lead program focuses on the development of a recombinant protein for the treatment of stroke, aiming to provide viable treatments for stroke patients in the days following the event, where currently there are no available options. Elevian's medicines have the potential to not only treat stroke but also prevent and address various aging-associated diseases. With stroke being a leading cause of long-term disability and the second leading cause of death globally, Elevian's research and development efforts are centered around promoting regeneration and recovery in the hours and days following a stroke. Their recombinant protein, rGDF11, has shown promising results in facilitating motor function recovery in animal models of both ischemic and hemorrhagic stroke. Additionally, rGDF11 has demonstrated potential in promoting recovery and regeneration in various preclinical models of aging-related diseases, including cardiovascular, neurological, metabolic, pulmonary, renal, inflammatory, and skeletal muscle dysfunction.Generated from the website

BioSensics LLC is a global leader in the development of wearable sensors and digital platforms for clinical trials, patient monitoring, and health assessment, offering advanced technologies for effective measurement and analysis of digital biomarkers and health data. With their turnkey products, including wearable sensors, mobile health applications, and medical devices, BioSensics revolutionizes clinical trials and research, patient monitoring, and health assessment, providing comprehensive operational and technical services for these purposes.Generated from the website